Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

Some Companies Will Make Big Money Off Their COVID-19 Vaccines - But Not as Much as They Could

CBC, November 25, 2020

While the development of a COVID-19 vaccine could generate billions of dollars for some pharmaceutical companies such as Pfizer, concerns over accusations of exploiting the pandemic will likely temper profits, experts suggest. "It doesn't really make sense to profit from this pandemic," said Tinglong Dai, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore.

What's the Science Behind COVID Business Capacity Limits?

What's the Science Behind COVID Business Capacity Limits?

Las Vegas Review-Journal, November 25, 2020

New restrictions imposed on restaurants and other businesses this week by Gov. Steve Sisolak to curb the spread of COVID-19 raise a question: What’s the science behind them? The science is imperfect, broad in stroke and balanced by policy and political considerations, health authorities said. “The basic idea is we are trying to reduce the density of people in any environment,” said epidemiologist Brian Labus, a member of the governor’s medical advisory team on COVID-19.

Vaccine Resisters Could Derail Island's COVID-19 Recovery, Experts Say

Vaccine Resisters Could Derail Island's COVID-19 Recovery, Experts Say

Newsday, November 29, 2020

Delivering an effective vaccine is only part of the equation. The region's recovery from COVID-19 also will hinge on Long Islanders' willingness to take the shot, experts say. The public's appetite for inoculations will be a wild card, said Julie Swann, an expert in health care supply chains who advised the Centers for Disease Control and Prevention during the H1N1 outbreak in 2009.

Pfizer's COVID Vaccine Comes With a Chilly Complication. But That May Change.

Pfizer's COVID Vaccine Comes With a Chilly Complication. But That May Change.

Fortune, November 28, 2020

Pfizer’s coronavirus vaccine candidate, announced earlier this month, comes with a major complication that could delay its distribution in rural areas and developing countries: It must be stored at the ultra-cold temperature of -70°C. That means the vaccine must be kept in specialized freezers that cost as much as $20,000 each and are rare outside of medical research facilities.

What Will It Take to Get a COVID-19 Vaccine to the World?

What Will It Take to Get a COVID-19 Vaccine to the World?

New Scientist, November 18, 2020

In Kalamazoo, Michigan, millions of vials of a covid-19 vaccine may soon be rolling off production lines. There are still many hurdles to leap before that vaccine – the candidate from US drug company Pfizer and its German partner BioNTech – or any other is approved and distributed, but governments, manufacturers and shipping firms around the world have already spent months preparing for what happens next.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

AI’s energy impact is still small—but how we handle it is huge

AI’s energy impact is still small—but how we handle it is huge

DJNews, May 21, 2025

With seemingly no limit to the demand for artificial intelligence, everyone in the energy, AI, and climate fields is justifiably worried. Will there be enough clean electricity to power AI and enough water to cool the data centers that support this technology? These are important questions with serious implications for communities, the economy, and the environment. 

Healthcare

Want to reduce the cost of healthcare? Start with our billing practices.

Want to reduce the cost of healthcare? Start with our billing practices.

The Hill, March 11, 2025

Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive. 

Supply Chain

US-China 90-day tariff deal brightens trade and economic outlook

US-China 90-day tariff deal brightens trade and economic outlook

Fast Markets, May 13, 2025

The recent US-China agreement to temporarily reduce tariffs is a major step for global trade, with tariffs on US goods entering China dropping from 125% to 10% and on Chinese goods entering the US decreasing from 145% to 30% starting May 14. While this has boosted markets and created optimism, key industries like autos and steel remain affected, leaving businesses waiting for clearer long-term trade policies.

Items to Stock Up on Before Trump's Tariffs Take Effect

Items to Stock Up on Before Trump's Tariffs Take Effect

Newsweek, May 8, 2025

With sweeping new tariffs on Chinese-made products set to take effect this summer, Americans are being urged to prepare for price hikes on everyday goods. President Donald Trump's reinstated trade policies are expected to affect a wide swath of consumer imports, including electronics, furniture, appliances, and baby gear. Retail experts are advising shoppers to act before the tariffs hit and prices rise.

Climate